Acumen Pharmaceuticals, Inc. ABOS

Set alert

Price alert · ABOS

All alert types
0.24 USD +0.03 +15.47%

As of Nov 2, 10:48 AM ET

Bid
0.24 × 2
Ask
0.25 × 1
0.198 Day range 0.2574
0.198 52-week range 3.60
YTD
-88.50%
1 year
-89.02%
Open
0.2004
Prev close
0.2101
Mkt cap
17.43M
Vol
14.58M
Avg vol
1.56M
EPS
-1.55
P/E
0.00
Div yield
0.00%
More statistics
Low
0.198
High
0.2574
Forward P/E
-1.17
Beta
0.04
Short ratio
6.61
Inst. own
78.46%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
2.48
200-d avg
2.89
1y target
10.80

MAX chart

Chart tools
Interval

Events in this range
  • Mar 26, 2024Earnings: —; estimate -0.29; surprise —%
  • May 14, 2024Earnings: -0.25; estimate -0.23; surprise -8.7%
  • May 14, 2024Earnings: —; estimate -0.23; surprise —%
  • May 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Jul 25, 2024Rating: Citigroup · — → Buy
  • Aug 13, 2024Earnings: —; estimate -0.28; surprise —%
  • Aug 13, 2024Earnings: -0.34; estimate -0.28; surprise -21.43%
  • Aug 14, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Aug 15, 2024Rating: UBS · Buy → Buy
  • Oct 3, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 12, 2024Earnings: -0.5; estimate -0.36; surprise -38.89%
  • Nov 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (104)
NameDateAgo
RSI: OversoldOct 26, 20261 week ago
SMA: BearishSep 21, 20261 month ago
MACD: Sell SignalSep 21, 20261 month ago
MACD: Buy SignalAug 17, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BullishJun 29, 20264 months ago
SMA: BullishJun 29, 20264 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 25, 20265 months ago
SMA: BullishMay 18, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BullishApr 13, 20266 months ago
MACD: Sell SignalApr 6, 20267 months ago
SMA: BearishMar 23, 20267 months ago
RSI: OverboughtFeb 23, 20268 months ago
MACD: Buy SignalJan 26, 20269 months ago
SMA: BullishJan 19, 20269 months ago
SMA: BearishJan 5, 202610 months ago
MACD: Sell SignalJan 5, 202610 months ago
SMA: BullishDec 8, 202510 months ago
SMA: BearishNov 10, 202511 months ago
SMA: BullishSep 22, 20251 year ago
SMA: BearishSep 8, 20251 year ago
SMA: BullishSep 1, 20251 year ago
SMA: BearishAug 25, 20251 year ago
SMA: BullishJul 7, 20251 year ago
SMA: BullishJun 2, 20251 year ago
MACD: Buy SignalApr 21, 20251 year ago
RSI: OversoldApr 14, 20251 year ago
RSI: OversoldMar 31, 20251 year ago
MACD: Sell SignalDec 2, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BullishOct 21, 20242 years ago
SMA: BullishOct 14, 20242 years ago
MACD: Buy SignalOct 14, 20242 years ago
MACD: Sell SignalSep 30, 20242 years ago
MACD: Buy SignalSep 9, 20242 years ago
MACD: Sell SignalSep 2, 20242 years ago
SMA: BearishAug 26, 20242 years ago
SMA: BullishAug 19, 20242 years ago
SMA: BearishAug 5, 20242 years ago
SMA: BearishJul 29, 20242 years ago
SMA: BullishJul 22, 20242 years ago
MACD: Buy SignalJul 22, 20242 years ago
SMA: BullishJul 15, 20242 years ago
SMA: BearishMay 27, 20242 years ago
MACD: Sell SignalMay 20, 20242 years ago
MACD: Buy SignalMay 13, 20242 years ago
SMA: BullishApr 29, 20242 years ago
MACD: Sell SignalApr 22, 20242 years ago
SMA: BearishApr 15, 20242 years ago
SMA: BearishApr 8, 20242 years ago
SMA: BullishFeb 26, 20242 years ago
SMA: BullishFeb 19, 20242 years ago
SMA: BearishJan 22, 20242 years ago
MACD: Buy SignalDec 25, 20232 years ago
SMA: BullishDec 11, 20232 years ago
RSI: OversoldOct 23, 20233 years ago
SMA: BearishSep 18, 20233 years ago
MACD: Sell SignalSep 11, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BullishJul 3, 20233 years ago
SMA: BearishJun 26, 20233 years ago
SMA: BearishJun 26, 20233 years ago
SMA: BullishJun 12, 20233 years ago
SMA: BearishMay 22, 20233 years ago
SMA: BullishMay 8, 20233 years ago
MACD: Buy SignalMay 8, 20233 years ago
SMA: BullishMay 1, 20233 years ago
SMA: BearishFeb 13, 20233 years ago
SMA: BullishJan 30, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BearishDec 12, 20223 years ago
SMA: BullishDec 5, 20223 years ago
SMA: BearishNov 28, 20223 years ago
MACD: Sell SignalNov 21, 20223 years ago
SMA: BearishOct 31, 20224 years ago
SMA: BullishSep 26, 20224 years ago
SMA: BullishSep 26, 20224 years ago
SMA: BearishSep 19, 20224 years ago
SMA: BearishSep 12, 20224 years ago
SMA: BullishAug 22, 20224 years ago
SMA: BearishAug 15, 20224 years ago
SMA: BullishJul 4, 20224 years ago
SMA: BullishJun 20, 20224 years ago
SMA: BearishJun 13, 20224 years ago
RSI: OversoldJun 13, 20224 years ago
SMA: BullishJun 6, 20224 years ago
RSI: OversoldMar 28, 20224 years ago
SMA: BearishMar 21, 20224 years ago
SMA: BullishMar 7, 20224 years ago
SMA: BullishFeb 14, 20224 years ago
RSI: OversoldNov 15, 20214 years ago
SMA: BearishSep 13, 20215 years ago
SMA: BullishSep 6, 20215 years ago

Financial health

Altman Z-Score

-11.70 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -1.1×
FY 2019: -101×FY 2020: -77.3×FY 2021: -2.6×FY 2022: -5.1×FY 2023: -3.6×FY 2024: -1.0×FY 2025: -1.1×
FY 2019 5y median -2.6× FY 2025
P/S 0.0×
FY 2019: 339×FY 2020: 401×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.8×
FY 2019: -50.4×FY 2020: -31.0×FY 2021: 1.1×FY 2022: 1.2×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 1.8×
FY 2019 5y median 1.1× FY 2025
P/FCF -1.1×
FY 2019: -84.5×FY 2020: -77.3×FY 2021: -14.4×FY 2022: -6.2×FY 2023: -4.3×FY 2024: -1.2×FY 2025: -1.1×
FY 2019 5y median -4.3× FY 2025
EV/EBITDA -0.9×
FY 2019: 0.0×FY 2020: -67.3×FY 2021: -1.4×FY 2022: -2.1×FY 2023: -2.9×FY 2024: -1.0×FY 2025: -0.9×
FY 2019 5y median -1.4× FY 2025
EV/Sales 0.0×
FY 2019: 336×FY 2020: 371×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -90.5%
FY 2019: -1.2%FY 2020: -1.3%FY 2021: -7.0%FY 2022: -16.1%FY 2023: -23.1%FY 2024: -83.5%FY 2025: -90.5%
FY 2019 5y median -23.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: -405.4%FY 2020: -456.9%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019: -459.9%FY 2020: -551.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019: -465.9%FY 2020: -510.1%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -172.3%
FY 2019: 69.2%FY 2020: 39.4%FY 2021: -44.7%FY 2022: -22.7%FY 2023: -19.6%FY 2024: -56.3%FY 2025: -172.3%
FY 2019 5y median -44.7% FY 2025
ROIC -121.7%
FY 2019: -130.5%FY 2020: -20.8%FY 2021: -8.7%FY 2022: -24.0%FY 2023: -20.5%FY 2024: -53.9%FY 2025: -121.7%
FY 2019 5y median -24.0% FY 2025
ROA -98.8%
FY 2019: -108.0%FY 2020: -16.5%FY 2021: -43.7%FY 2022: -21.8%FY 2023: -16.9%FY 2024: -42.8%FY 2025: -98.8%
FY 2019 5y median -42.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: -15.4%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 FY 2025
Operating Income -8.6%
FY 2019: 0.0%FY 2020: -1.4%FY 2021: -147.5%FY 2022: -131.0%FY 2023: -35.2%FY 2024: -86.5%FY 2025: -8.6%
FY 2019 FY 2025
EPS (diluted) -17.0%
FY 2019: 0.0%FY 2020: 3.7%FY 2021: -911.5%FY 2022: 59.7%FY 2023: -1.9%FY 2024: -58.3%FY 2025: -17.0%
FY 2019 FY 2025
Free Cash Flow -34.1%
FY 2019: 0.0%FY 2020: -9.3%FY 2021: -141.6%FY 2022: -96.2%FY 2023: -22.0%FY 2024: -100.1%FY 2025: -34.1%
FY 2019 FY 2025

Financial Health

Current Ratio 4.1×
FY 2019: 5.3×FY 2020: 7.0×FY 2021: 38.6×FY 2022: 23.1×FY 2023: 19.0×FY 2024: 6.5×FY 2025: 4.1×
FY 2019 5y median 19.0× FY 2025
Quick Ratio 4.1×
FY 2019: 5.3×FY 2020: 7.0×FY 2021: 38.6×FY 2022: 23.1×FY 2023: 19.0×FY 2024: 6.5×FY 2025: 4.1×
FY 2019 5y median 19.0× FY 2025
Debt / Equity 0.4×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.4×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2019: 0.0×FY 2020: 5.5×FY 2021: 1.2×FY 2022: 3.0×FY 2023: 0.7×FY 2024: 0.1×FY 2025: 0.2×
FY 2019 5y median 0.7× FY 2025
Interest Coverage -29.3×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -105×FY 2024: -28.0×FY 2025: -29.3×
FY 2019 5y median -28.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31